<DOC>
	<DOCNO>NCT00554970</DOCNO>
	<brief_summary>The purpose study examine blood level two dos MAP0010 ( corticosteroid ) two dos approve corticosteroid adult asthma safety twice daily dose 7 day .</brief_summary>
	<brief_title>A Study 2 Doses MAP0010 Adult Asthmatics</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Male female adult asthmatic mild moderate persistent asthma . 18 45 ( 46th birthday ) year age . Documented diagnosis asthma least 3 month prior Visit 1 , per NIH/NHLBI , EPR3 criterion . Able withhold shortacting bronchodilator ( e.g. , albuterol ipratropium bromide ) least 4 hour prior clinic visit . Baseline FEV1 great equal 50 % predict normal . Any significant illness/abnormality A history upper low respiratory tract infection within 2 week A history acute severe asthma attack require ICU admission ventilatory support .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Adult Asthmatics</keyword>
</DOC>